Karen Smith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
-
Current
2024-01-01–present
-
Quince Therapeutics, Inc. (QNCX)
Proxy statement
Current -
Emergent BioSolutions Inc. (EBS)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Quince Therapeutics, Inc. (QNCX) | M.D., Ph.D. Former Chief Medical Officer | $336,458 | $1,347,920 |
| 2022 | Quince Therapeutics, Inc. (QNCX) | M.D., Ph.D. Former Chief Medical Officer | $273,734 | $3,485,274 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.